Skip to main content
Equibles

Swiss National Bank

Bank

Position in MLTX — MoonLake Immunotherapeutics

CIK 1582202 ZURICH, V8
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,695,837
+$549,477 QoQ
Shares Held
87,100
+41.6% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 172 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. MLTX ranks #115 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in MLTX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,695,837 87,100
2026-03-31 $1,146,360 61,500
2025-12-31 $810,570 61,500
2025-09-30 $308,310 43,000
2025-06-30 $1,996,560 42,300
2025-03-31 $1,680,010 43,000
2024-12-31 $2,328,450 43,000
2024-09-30 $2,168,060 43,000
2024-06-30 $1,358,673 30,900
2024-03-31 $1,773,119 35,300
2023-12-31 $2,131,767 35,300
2023-09-30 $2,268,600 39,800